Moxidectin

Chemical Namemoxidectin
Dosage FormTablet (oral; 2 mg)
Drug ClassAntihelminthics
SystemOcular, Skin
CompanyMDGH
Approval Year2018

Indication

  • Moxidectin is indicated for the treatment of onchocerciasis due to Onchocerca volvulus in patients aged 12 years and older.
Last updated on 10/19/2020

More on this drug: Clinical Trials

Have we missed a study, or would you like to comment on a study?

Document TitleYearSource
Moxidectin (moxidectin) Prescribing Information2019MDGH